Novo Nordisk has decided to resubmit the New Drug Applications of Tresiba® and Ryzodeg® in the US
27 March 2015 | By Victoria White
Novo Nordisk has announced that it has decided to resubmit New Drug Applications of Tresiba and Ryzodeg to the FDA within the month.